Innate Pharma (France)

Innate Pharma (France)

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2024.

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

58%


Total
Publications

564


Total Open
Publications

329


Total
Citations

31K


Open Access
Percentage

58%


Total
Publications

564


Total Open
Publications

329


Total
Citations

31K

Website

download

Breakdown

18% 27% 13% 42%

Publisher Open

18%

Both

27%

Other Platform Open

13%

Closed

42%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035404550Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

72

Hybrid 32%

81

No Guarantees 39%

99

Other Platform Open

Domain 74%

170

Institution 41%

94

Other Internet 21%

49

Preprint 9%

21

Public 9%

20

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
167
Europe PMC
Domain
104
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
34
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
33
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
28
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université
Institution
24
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
20
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
20
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
14
Semantic Scholar
Public
12
1 / 8

Data updated 7 April 2025

Share

Share

Share